Devintec OR-AT0222 Oral Gel for the Treatment of Canker Sores: A Double Blind, Randomized, Placebo Controlled Clinical Investigation
Recurrent Aphthous Ulcer
About this trial
This is an interventional treatment trial for Recurrent Aphthous Ulcer focused on measuring aphthous ulcer, canker sores, aphthous stomatitis, Topical oral gel
Eligibility Criteria
Inclusion Criteria: >18 years (male and females) Patients have one oral canker sore, at least. Onset within 48 hours Patients in good condition with no serious systemic disease Exclusion Criteria: Hypersensitivity to any OR-AT0222 ingredients Use of any medication to treat the ulcers the previous week before ORAT0222 gel use started or use of local medication or systemic drug during the treatment with OR-AT0222 gel. Underlying systemic disease(s) or a history of immunologic disorder(s); Taking immunomodulatory agents or systemic nonsteroidal antiinflammatory drugs < 1 month before study commencement; Smokers; Could not provide written informed consent
Sites / Locations
- Policlinico "Umberto I" - U.O.C. di Odontoiatria Pediatrica ed OdontostomatologiaRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Group 1
Group 2
Treatment with OR-AT0222
Treatment with Placebo